Biogen Inc. (BIIB)
NASDAQ: BIIB · IEX Real-Time Price · USD
226.40
+1.15 (0.51%)
At close: Jul 19, 2024, 4:00 PM
226.99
+0.59 (0.26%)
Pre-market: Jul 22, 2024, 5:00 AM EDT
Biogen Stock Forecast
Stock Price Forecast
The 23 analysts with 12-month price forecasts for Biogen stock have an average target of 286.26, with a low estimate of 200 and a high estimate of 373. The average target predicts an increase of 26.44% from the current stock price of 226.40.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Biogen stock from 23 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 7 | 7 | 7 |
| Buy | 10 | 10 | 9 | 9 | 9 | 9 |
| Hold | 6 | 6 | 7 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 25 | 25 | 25 | 23 | 23 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $335 → $313 | Buy | Maintains | $335 → $313 | +38.25% | Jul 12, 2024 |
| Needham | Needham | Strong Buy Reiterates $294 | Strong Buy | Reiterates | $294 | +29.86% | Jun 28, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $317 | Buy | Reiterates | $317 | +40.02% | Jun 27, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $317 | Buy | Reiterates | $317 | +40.02% | Jun 26, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $317 | Buy | Reiterates | $317 | +40.02% | Jun 5, 2024 |
Financial Forecast
Revenue This Year
9.71B
from 9.84B
Decreased by -1.26%
Revenue Next Year
9.75B
from 9.71B
Increased by 0.35%
EPS This Year
15.94
from 7.97
Increased by 99.95%
EPS Next Year
17.73
from 15.94
Increased by 11.26%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.2B | 10.9B | 12.0B | 12.9B | 14.3B |
| Avg | 9.7B | 9.7B | 10.1B | 10.5B | 10.9B |
| Low | 9.2B | 8.4B | 8.3B | 8.7B | 8.8B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.9% | 12.1% | 22.9% | 27.0% | 36.3% |
| Avg | -1.3% | 0.4% | 4.0% | 3.6% | 4.2% |
| Low | -6.8% | -13.1% | -14.5% | -14.0% | -16.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 17.19 | 21.95 | 28.51 | 27.46 | 30.29 |
| Avg | 15.94 | 17.73 | 19.77 | 21.39 | 23.27 |
| Low | 14.80 | 13.48 | 12.69 | 14.81 | 15.84 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 115.7% | 37.7% | 60.8% | 38.9% | 41.6% |
| Avg | 100.0% | 11.3% | 11.5% | 8.2% | 8.8% |
| Low | 85.7% | -15.4% | -28.4% | -25.1% | -26.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.